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abstract
Objective: To estimate the cost of hospitalization of patients with severe sepsis or septic 
shock admitted or diagnosed in the Urgent and Emergency sector at a university hospital 
and followed until the clinical outcome. Method: An epidemiological, prospective, 
observational study conducted in a public hospital in southern Brazil for the period of 
one year (August 2013 to August 2014). Sepsis notification forms, medical records and 
data of the cost sector were used for the collection of clinical and epidemiological data. 
Results: The sample comprised 95 patients, resulting in a total high cost of hospitalization 
(R$ 3,692,421.00), and an average of R$ 38,867.60 per patient. Over half of the total value 
of the treatment of sepsis (R$ 2,215,773.50) was assigned to patients who progressed to 
death (59.0%). The higher costs were related to discharge, diagnosis of severe sepsis, the 
pulmonary focus of infection and the age group of up to 59 years. Conclusion: The high 
cost of the treatment of sepsis justifies investments in training actions and institution 
of protocols that can direct preventive actions, and optimize diagnosis and treatment in 
infected and septic patients.
descriPtOrs
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INTRODUCTION
Sepsis is defined as a Systemic Inflammatory Response 
Syndrome (SIRS) triggered by a suspected or confirmed 
infection that can develop into severe sepsis when associ-
ated with organ dysfunction or septic shock(1-2). This disease 
is a public health problem and a challenge for healthcare 
organizations because it is among the leading death causes 
in hospitalized patients(3).
Despite technological and therapeutic advances, sepsis 
affects people of all age groups and genders, and is related 
to the high prevalence of mortality (30-60%)(4). According 
to the Instituto Latino Americano da Sepse, the syndrome 
is the leading cause of death in Intensive Care Units (ICU) 
and a major cause of delayed hospital mortality, beating 
myocardial infarction and cancer(5).
Given the high lethality, severe sepsis and septic shock 
are one of the main cost-generating conditions in public 
and private sectors related to hospitalizations and treat-
ment, and organ complications and dysfunction. This is ex-
plained by the demands of this condition, such as replace-
ment therapy for organ dysfunction, high-cost drugs and 
thorough patient follow-up by the health team(6).
According to the report of the Surviving Sepsis 
Campaign, in 2003 were reported 398,000 cases and 
227,000 deaths from septic shock in Brazil(5). Approximately 
R$ 17.3 billion are used annually in the treatment of septic 
patients, of which R$ 10 billion are targeted to patients 
progressing to death, generating economic impact(5,7).
The high mortality of septic shock and severe sep-
sis, and high costs associated with their treatment show 
the need for prevention and early diagnosis(8). Therefore, 
knowing the costs generated by sepsis in health services 
can help to estimate the economic and social burden, and 
reinforces the importance of preventive measures. Given 
the above, the aim of this study was to estimate the cost 
of hospitalization of patients with severe sepsis or septic 
shock admitted or diagnosed in the Urgent and Emergency 
sector of a university hospital who were followed until the 
clinical outcome.
METHOD
This is an epidemiological, prospective, observational 
study involving all adult patients admitted or diagnosed 
with severe sepsis or septic shock in the Urgent and 
Emergency sector of the university hospital in southern 
Brazil between August 2013 and August 2014.
The inclusion criteria were all patients aged over 14 
years, diagnosed with severe sepsis or septic shock ac-
cording to the current sepsis criteria (International Sepsis 
Definitions Conference)(9) during assistance in the Urgent 
and Emergency sector. Cases of death within the first 24 
hours of care were excluded.
The analysis variables were the following: gender, age of 
patient, focus of infection (Centers for Disease Control and 
Prevention/National Healthcare Safety Network)(10), hos-
pitalization period, health care cost, and clinical outcome 
(discharge or death). The patient follow-up starting from 
their admission to institution until the clinical outcome al-
lowed the mapping of hospitalization in different sectors: 
Urgent and Emergency, Intensive Care Unit (ICU) and 
medical-surgical inpatient units. Note that patients did not 
remain in the Urgent and Emergency sector throughout 
the whole period of hospital stay, but were referred to other 
hospital departments such as female or male inpatient units 
and Intensive Care Units.
Data collection was performed through sepsis notifica-
tion forms of the management sepsis protocol of the insti-
tution recommended by the Instituto Latino Americano 
de Sepse(5), medical records, and data from the cost sector. 
The notification forms had patient identification, gender, 
age, focus of infection, severe and shock sepsis classification 
criteria, date and time of organ dysfunction diagnosis.
The cost sector has provided the average daily costs 
corresponding to the months of the study referring to the 
hospitalization days in the respective sectors. The direct 
costs were considered to calculate the average hospitaliza-
tion cost of patients per unit, namely: personnel and taxes, 
outsourced services, materials and medicines. The indirect 
costs consisting of apportionment costs of support services 
were also considered, such as laundry, maintenance, etc., as 
well as apportionment costs of the examination structure 
and/or clinical, medical and hospital procedures.
Next, the patients’ hospitalization costs were estimated 
by using hospitalization stay (days) versus the average daily 
cost per admission unit corresponding to the period of hos-
pital stay. The estimated cost is considered as the sum of 
hospitalization days multiplied by the daily value/inpatient 
unit. The calculation of costs in US dollars (US$) consid-
ered the value of US$ 1 = R$ 2.239, according to the ex-
change rate quoted in August 2014.
The Statistical Package for the Social Sciences (SPSS) 
version 20 was used for tabulation and data analysis. 
Categorical variables were analyzed in the form of simple 
frequency, medians and quartiles, shown in tables and fig-
ures. The comparison between variables was performed by 
Pearson’s and Mann-Whitney tests, and the significant 
difference was established at p ≤ 0.05. The dispersion of 
data was performed according to hospitalization days and 
hospital costs. The cost results were presented as median 
and interquartile range. Threshold values (called outli-
ers) were presented to demonstrate the variation of hos-
pitalization period, which can be affected by several fac-
tors. This study was approved by the Ethics Committee 
on Research involving Human Beings (Process number 
884 268) and the Certificate of Presentation for Ethical 
Consideration (CAAE – Certificado de Apresentação para 
Apreciação Ética) number 0015.0.268.000-11 is available 
for public consultation.
RESULTS
Of the 95 patients, 56 (58.9%) were identified with se-
vere sepsis and 39 (41.1%) with septic shock. Of all patients 
admitted to the studied institution, 43.3% had some organ 
dysfunction related to sepsis, and the others have developed 
sepsis during hospitalization in the Urgent and Emergency 
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sector. As for epidemiological variables, female gender was 
more frequent (52.6%), and the age range was 18-98 years, 
mean of 64.19 years (SD-24.4). The median length of hos-
pital stay was 17 days, ranging between 1-147 days, 24 days 
on average (SD-24.4).
Regarding the focus of infection, some patients had 
more than an infection related to sepsis, totaling 102 infec-
tions. The patient infection rate showed a predominance of 
pulmonary focus (n = 73; 76.8%) corresponding to pneu-
monia, urinary tract infection (n = 10; 8.4%), both infec-
tions (n = 8; 8.4%), abdominal infection (n = 3; 3.2%) ab-
dominal focus, and associated abdominal and osteoarticular 
infections (n = 1, 1%).
As illustrated in Figure 1, in relation to the classification 
of sepsis and clinical outcome among patients with severe 
sepsis criteria (56), just over half were discharged (51.8%), 
and among patients with septic shock (39), the majority 
died (74.4%). We observed that septic shock was associated 
with higher incidence of death (74.3%; p = 0.017).
The average cost of hospitalization of septic patients was 
R$ 38,867.60 (US$ 17,359.30) and the sum of the cost of all 
patients was R$ 3,692,421.00 (US$ 1,649,138.40). The data 
for hospitalization calculations made available by the cost 
sector are shown in Table 1. The distribution of expendi-
tures according to the clinical outcome, sepsis classification, 
patient’s age and associated factors are shown in Table 2.
Table 1 – Statement of average daily costs (in real and American dollar) of the hospital units where patients were hospitalized. 
Londrina, PR, Brazil, 2015.
sectOrs
Patient/day
august
2013
september
2013
October
2013
november
2013
december
2013
January
2014
February
2014
March
2014
april
2014
May
2014
June
2014
July
2014
august
2014
icU – 1
Real 3,029.70 3,121.01 2,917.84 3,022.38 3,007.83 3,605.30 2,915.90 2,981.49 2,993.37 5,545.05 3,967.24 3,349.09 3,177.08
Dollar 1,353.15 1,393.93 1,303.19 1,349.88 1,343.38 1,610.23 1,302.32 1,331.62 1,336.92 2,476.57 1,771.88 1,495.80 1,418.97
icU – 2
Real 3,654.04 4,036.91 3,618.80 4,161.54 3,802.84 4,442.61 3,845.08 3,740.63 3,784.13 4,254.07 4,227.36 4,159.35 4,184.31
Dollar 1,632.00 1,803.00 1,616.26 1,858.66 1,698.45 1,984.19 1,717.32 1,670.67 1,690.10 1,899.99 1,888.06 1,857.68 1,868.83
Male unit*
Real 1,170.08 1,008.23 1,199.91 1,158.08 1,284.05 1,083.32 1,198.33 1,282.68 1,204.25 1,222.90 1,350.32 1,566.82 1,473.20
Dollar 522.59 450.30 535.91 517.23 573.49 483.84 535.21 572.88 537.85 546.18 603.9 699.79 657.97
Female unit**
Real 1,015.50 1,189.56 1,313.67 1,070.52 1,290.90 1,221.96 1,186.43 1,239.57 1,247.12 1,179.46 1,264.52 1,196.66 1,168.47
Dollar 453.55 531.29 586.72 478.12 576.55 545.76 529.89 553.63 557.00 526.78 564.77 534.46 521.87
communicable diseases
Real 1,313.43 1,248.31 1,038.32 1,257.16 1,931.73 1,179.37 1,260.90 1,141.36 944.57 1,467.44 1,156.88 1,275.19 1,321.32
Dollar 586.61 557.53 463.74 561.48 862.76 526.74 563.15 509.76 421.87 655.40 516.69 569.54 590.14
Urgent and emergency
Real 917.79 1,095.90 1,106.95 960.98 1,114.92 1,026.27 1,031.11 970.91 924.63 874.58 1,115.43 1,200.72 1,164.57
Dollar 409.91 489.46 493.99 429.20 497.95 458.36 460.52 433.64 412.97 390.61 498.18 536.28 520.13
*Male inpatient unit. **Female inpatient unit
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Figure 1 – Distribution of severe sepsis and septic shock diagnosis 
according to the patients’ outcome – Londrina, Paraná, Brazil, 2015.
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Table 2 – Hospital costs related to clinical outcome and diagnosis of sepsis, focus of infection and patients’ age – Londrina, Paraná, 
Brazil, 2015.
total cost Median interquartiles (1st and 3rd)
Mann-Whitney test
real dollar real dollar real dollar
Outcome
Hospital discharge 1,476,647.53 659,512.07 22,945.00 1,0247.88 1st 9,993.00 4,463.15
0.431 (p=0.001)
3rd 49,836.00 22,258.15
Death 2,215,773.47 989,626.38 18,833.50 8,411.57 1st 6,932.50 3,096.25
3rd 51,861.00 23,162.57
Classification of sepsis
Severe sepsis 2,348,402.90 1,048,862.39 24,837.50 11,093.12 1st 10,588.00 4,728.90
0.518 (p=0.001)
3rd 53,346.00 23,825.81
Septic shock 1,344,018.10 600,276.06 17,221.00 7,691.38 1st 8,234.00 3,677.53
3rd 49,836.00 22,258.15
Focus of infection*
Pulmonary 2,908,378.00 1,298,962.93 20,389.00 9,106.30 1st 8,742.00 3,904.42
0.345 (p=0.001)
3rd 40,825.50 18,233.81
Urinary tract 723,328.00 323,058.51 17,221.00 7,691.38 1st 5,095.00 2,275.57
3rd 55,800.00 24,921.84
age group
Up to 59 years (n=32) 1,295,281.00 578,508.71 29,679.00 13,255.47 1st 8,495.50 3,794.33
0.556 (p=0.001)
3rd 63,248.25 28,248.44
60 years or older (n=63) 2,397,140.00 1,070,629.74 19,220.00 8,584.19 1st 8,738.00 3,902.63
3rd 33,218.00 14,836.09
* Patients with exclusive pulmonary or urinary focus of infection were included in this calculation.
The results showed that the higher costs are related to 
the clinical outcome of discharge, diagnosis of severe sep-
sis, pulmonary focus of infection, and the age group of up 
to 59 years (Table 1). There was also a positive correlation 
between costs and hospitalization days (r = 0.826; p = 0.01), 
i.e., the length of hospitalization interferes with costs. 
Thus, the longer the hospital stay, the higher the hospital 
costs (Figure 2).
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Figure 2 – Dispersal of the data according to hospitalization days and hospital costs in real currency. Londrina, Paraná, Brazil, 2015.
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For statistical analysis, we decided to keep the extreme 
values of two patients hospitalized for 134 and 147 days, 
respectively. They express the reality of health services, in 
which prolonged hospitalization significantly increases the 
therapeutic costs of certain health problems and the hos-
pitalization costs of R$ 364,355.6 (US$ 162,731.5) and 
R$ 174,076.9 (US$ 77,747.6) considered with the outliers.
DISCUSSION
Sepsis is a major health problem given its high mortal-
ity and morbidity. Regarding the management of financial 
resources of health services, this medical condition results 
in high costs and resources spent.
The study results are in agreement with this sce-
nario, showing the high total cost (R$ 3,692,421.00; 
US$ 1,649,138.00) in the treatment of patients admitted or 
diagnosed with severe sepsis or septic shock in the Urgent 
and Emergency sector of the institution during a one-year 
period. In this perspective, a multicenter observational co-
hort study was performed in Brazil in 2008 with septic pa-
tients admitted to 21 ICUs of public and private hospitals. 
During a year, participants were followed from diagnosis of 
sepsis until the clinical outcome and the direct hospitaliza-
tion costs were estimated. The results showed an average 
total cost per patient of US$ 9,632.00 (R$ 21,566.00)(11).
This value is below that calculated in the current study, 
which was R$ 38,867.6 (US$ 17,359.30) per septic patient, 
on average. The divergence is explained by the different 
scenarios of both studies because the multicenter study in-
volved only ICUs, while the present study followed septic 
patients from admission until different hospital units.
Illustrating the European reality, a study performed in 
Ireland in 2014 found a relation between sepsis and fac-
tors that predict high hospital costs for patients admitted 
to the emergency room of secondary level hospitals, with 
an average of € 3,668.30 (R$ 6,045.50 and US$ 2,770.09)
(12). In France, the study identified 1698 patients with previ-
ous sepsis in the hospital admission unit and ICU, show-
ing the average cost of severe sepsis of US$ 22,800.00 
(R$ 51,049.20)(13). This cost is close to that found in the 
present study, considering the similar methodology of fol-
lowing patients since hospital admission.
A study performed in the United States also found 
higher costs than the results of the present study. In the 
American study, the individual cost calculated for adult 
patients was around US$ 21,000-25,000 (R$ 47,019.00-
55,975.00). For patients aged 1-19 years, the cost was 
US$ 28,000.00 (R$ 62,692.00). The study also estimated 
that sepsis can affect adults and the elderly more than chil-
dren (0.2/1,000 cases in children and 26.2/1,000 cases in 
> 85 years old)(7).
The mean age of patients was 64.19 years, corroborat-
ing authors who showed prevalence of organ dysfunction 
associated with sepsis in patients aged over 58 years(11,14-15).
Pneumonia and urinary tract infection were the 
main infectious focus of sepsis, and the pulmonary fo-
cus showed greater impact on costs (R$ 2,908,378.00, 
US$ 1,298.962.93), compared with the urinary focus 
(R$ 723,328.00, US$ 323,058.51). Both pneumonia(16) and 
urinary tract infection(12) are infectious foci commonly re-
lated to the evolution to sepsis. A prospective cohort study 
involving 14,364 patients hospitalized in international 
ICUs showed that among admitted septic patients, the 
predominant infectious foci were related to the respiratory, 
digestive and urinary tract. About 28% of total infections 
were associated with sepsis, 24% with severe sepsis, and 30% 
with septic shock(17).
As for hospitalization period, a study in Saudi Arabia 
with adult patients admitted between April 2007 and 
March 2010 in the medical-surgical ICU of a tertiary care 
hospital showed that patients with severe sepsis common-
ly had a prolonged stay in ICU and the hospital because 
of multiple organ failure and other disabilities related to 
sepsis(3). The average of the present study was close to 30 
days of hospitalization, indicating that even in a relatively 
short period the expenses with sepsis treatment are high. 
This is possibly related to the treatment of organ dysfunc-
tion resulting from sepsis, including intensive care, invasive 
procedures, mechanical ventilation, dialysis and high cost 
of broad-spectrum antibiotics. The hospitalization for this 
period also reflects the high lethality of sepsis.
Regarding the classification of sepsis, in the current 
study we observed higher costs in patients diagnosed with 
severe sepsis compared to those with septic shock. The hy-
pothesis for this result may be the severity of patients in 
shock. The majority of these patients progresses to death 
in short time, which would reduce the hospitalization 
period and, consequently, the costs with them. The same 
result was observed in a study conducted in France for a 
one-year period with the aim to document the costs and 
results for various forms of septic syndrome. The total aver-
age estimate for hospital costs were € 26,256, € 35,185 and 
€ 27,083 for patients with sepsis, severe sepsis and septic 
shock, respectively(18).
In a study conducted at the same institution that the 
present work, 46.5% of patients with infections related to 
health care have evolved with sepsis, increasing the risk of 
death by approximately six-fold (p <0.001, RR 5.87), com-
pared with patients who did not develop sepsis. The same 
study revealed septic shock was the most prevalent compli-
cation of sepsis (75%), with a mortality rate reaching 81.3% 
of patients(19).
Another negative scenario presented in a study 
showed that over half of the total value of sepsis treatment 
(R$ 2,215,773.50; US$ 989,626.00) was assigned to pa-
tients who progressed to death. This data is in agreement 
with international data, according to which over half of the 
full amount of money used in the treatment of septic pa-
tients (57.0%) was used in patients who died(5,7).
Still in Brazil, a multicenter observational cohort study 
was conducted in 2008 with septic patients hospitalized in 
21 ICUs of public and private hospitals for a one-year pe-
riod. Participants were followed since diagnosis of sepsis 
until the clinical outcome, and the direct costs of hospital-
ization were estimated. The results showed that the total 
average cost was US$ 9,632.00 (R$ 21,566.00) per patient, 
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and the average daily rate cost was significantly higher for 
non-survivors(11).
The presented data warn the institutions about the need 
for investment in professional training for the early diag-
nosis and implementation of treatment at the appropriate 
time, in order to be more effective and contribute with pa-
tients’ recovery, reducing the misdirection of investments 
that culminate in death(20).
The creation of a team for research and control of sepsis 
using management protocols for early diagnosis and appro-
priate treatment has proven an effective strategy to improve 
health indicators, such as reducing the chances of evolving 
to death by 30%, and reduction in days of hospital stay, 
which may reflect in reduction of hospital costs(20).
Note the limitation of this study having been performed 
in a teaching hospital, where many factors influence costs 
in comparison to other health institutions. However, it is 
exactly in teaching hospitals where cases of severe sepsis 
treated in the Unified Health System are referred, such as 
for tertiary reference services, and where data of costs are 
organized and available. Another limitation was that costs 
were not calculated from detailed analysis of medical re-
cords, but from average costs of the units. Although this can 
result in lower accuracy, it also represents an estimate in real 
values calculated monthly.
The high costs involved in the treatment of severe sep-
sis and septic shock justify investments in prevention, early 
diagnosis and appropriate treatment of patients with sep-
sis. Training activities and the establishment of protocols 
that target preventive actions and optimize diagnosis and 
treatment in infected and septic patients can help to re-
duce mortality and improve the management of financial 
resources of health institutions.
CONCLUSION
The estimated hospitalization costs of patients 
with severe sepsis and septic shock are equivalent to 
R$ 3,692,421.00 (US$ 1,649,138.40). The higher costs are 
related to discharge, diagnosis of severe sepsis, the pulmo-
nary focus of infection and the age group of up to 59 years.
resUMO
Objetivo: Estimar o custo da internação de pacientes com sepse grave ou choque séptico admitidos ou diagnosticados no setor de 
Urgências e Emergências de um hospital universitário e seguidos até o desfecho clínico. Método: Estudo epidemiológico, prospectivo 
e observacional, realizado em um hospital público do sul do Brasil, no período de 1 ano (agosto de 2013 a agosto de 2014). A coleta 
dos dados clínico-epidemiológicos utilizou fichas de notificação de sepse, prontuários e dados do setor de custos. Foi realizada análise 
de tendência central, dispersão e quartis dos custos das internações. Resultados: Amostra composta por 95 pacientes que totalizaram 
elevado custo da internação (R$ 3.692.421,00), com média de R$ 38.867,60 por paciente. Mais da metade do valor total do tratamento 
da sepse (R$ 2.215.773,50) destinou-se a pacientes que evoluíram a óbito (59,0%). Os maiores custos foram relacionados à alta, ao 
diagnóstico de sepse grave, ao foco infeccioso pulmonar e à faixa etária até os 59 anos. Conclusão: O elevado custo com o tratamento 
da sepse justificam investimentos em ações de capacitação e instituição de protocolos que possam direcionar ações preventivas, otimizar 
o diagnóstico e a terapêutica em pacientes infectados e séptico.
descritOres
Sepse; Infecção Hospitalar; Custos e Análise de Custo; Custos Hospitalares.
resUMen
Objetivo: Estimar el costo de la estancia hospitalaria de pacientes con sepsis severa o choque séptico ingresados o diagnosticados en el 
sector de Urgencias y Emergencias de un hospital universitario y seguidos hasta el resultado clínico. Método: Estudio epidemiológico, 
prospectivo y observacional, realizado en un hospital público del sur de Brasil, en el período de 1 año (agosto de 2013 a agosto de 2014). 
La recolección de los datos clínico-epidemiológicos utilizó fichas de notificación de sepsis, fichas clínicas y datos del sector de costos. Se 
llevó a cabo análisis de tendencia central, dispersión y cuartiles de los costos de las hospitalizaciones. Resultados: Muestra compuesta 
de 95 pacientes que totalizaron elevado costo de la hospitalización (R$ 3.692.421,00), con promedio de R$ 38.867,60 por paciente. 
Más de la mitad del valor total del tratamiento de la sepsis (R$ 2.215.773,50) se destinó a pacientes que llegaron a fallecer (59,0%). Los 
mayores costos estuvieron relacionados con el alta, el diagnóstico de sepsis severa, el foco infeccioso pulmonar y el rango de edad hasta 
los 59 años. Conclusión: El elevado costo con el tratamiento de la sepsis justifican inversiones en acciones de capacitación e institución 
de protocolos que puedan orientar acciones preventivas, optimizar el diagnóstico y la terapéutica en pacientes infectados y sépticos.
descriPtOres
Sepsis; Infección Hospitalaria; Costos y Análisis de Costo; Costos de Hospital.
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